Institutional Ownership
Aridis Pharmaceuticals Inc
CUSIP 040334104COMMON STOCKARDSQ1 2026
13D / 13G Filings
17
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
19.9%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
17 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Armistice Capital, LLC | 13G/A | 11.4% | 5.10M | SEC |
| 2 | Feb 17, 2026 | Armistice Capital, LLC | 13G/A | 9.4% | 1.51M | SEC |
| 3 | Aug 14, 2025 | Armistice Capital, LLC | 13G/A | 11.4% | 5.10M | SEC |
| 4 | Aug 14, 2025 | Armistice Capital, LLC | 13G | 6.6% | 703.6K | SEC |
| 5 | May 15, 2025 | Armistice Capital, LLC | 13G/A | 11.4% | 5.10M | SEC |
| 6 | Feb 14, 2025 | Armistice Capital, LLC | 13G/A | 11.4% | 5.10M | SEC |
| 7 | Nov 14, 2024 | Armistice Capital, LLC | 13G/A | 10.8% | 5.10M | SEC |
| 8 | Feb 14, 2024 | Armistice Capital, LLC | 13G/A | 10.0% | 4.63M | SEC |
| 9 | Feb 13, 2024 | Lind Global Fund II LP | 13G/A | — | — | SEC |
| 10 | Mar 20, 2023 | Lind Global Fund II LP | 13G | 8.3% | 3.00M | SEC |
7 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Aridis Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Strengthening Families & Communities, LLC | 3.0K | $1 |